Kendle International Inc. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Kendle International Inc.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Kendle International Inc.. The Group's principal activity is to provides Phase I-IV global clinical development services to the biopharmaceutical industry. It operates in two segments: Early Stage and Late Stage. The Early Stage segment focuses on the Group's Phase I operations, the high-end scientific exploratory medicine area. The Late Stage is comprised of clinical development services related to Phases II through IV, includes four reporting units: Global Clinical Development, Late Phase, Regulatory Affairs and Quality and Biometrics. The Global Clinical Development unit conducts Phase II and III clinical trials worldwide. The Late Phase unit designs and conducts Phase IIIB and IV studies worldwide. The Regulatory Affairs and Quality unit provides regulatory expertise and consulting services.The Biometrics unit offers customized clinical data management. It operates in the United States, Europe, Asia Pacific and Africa. In June 2008, it acquired DecisionLine Clinical Research Corporation.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report